Publication Beamlines Strategic Pillar
Lam, S. (2006). XAFS and XEOL Studies of Organic Light Emitting Materials. Canada, ON: University of Western Ontario. . SGM
Muir, D. (2006). Design of a High Performance Soft X-ray Spectrometer for the REIXS Beamline at the Canadian Light Source. Supervisor: Moewes, Alexander; Achenbach, Sven. Canada, SK: University of Saskatchewan. http://hdl.handle.net/10388/etd-11282006-142920. REIXS Materials
Smith, S. (2006). Front End X-ray Beam Position Monitors at the Canadian Light Source. Supervisor: Jiang, De-Tong; Bergstrom, Jack C.. Canada, SK: University of Saskatchewan. http://hdl.handle.net/10388/etd-10032006-135432. CMCF, HXMA Materials
Xu, D. (2006). Adsorption of Boric Acid on Pure and Humic Acid Coated Amorphous-Aluminum Hydroxide: A Raman and Xanes Spectroscopy Study. Canada, SK: University of Saskatchewan. . VLS-PGM
Procyshyn, Tara Lynn (2004). Saskatoon's agricultural biotechnology cluster and the Canadian Light Source: an assessment of the potential for cluster extension. Supervisor: Phillips, Peter W. B. Saskatchewan, Canada: University of Saskatchewan. http://hdl.handle.net/10388/etd-05282012-093059. Agriculture
Wishart, Jeffrey Daniel (2001). Transition Radiation Monitors at the Canadian Light Source. Supervisor: Bergstrom, Jack; Norum, Eric; Hirose, Akira. Saskatchewan, Canada: University of Saskatchewan. http://hdl.handle.net/10388/etd-06202012-091827. Materials
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.
フィリップ オコンネル、ジェイムズ; Philip O'connell James; フィリップ オコンネル、ジェイムズ; ロバート ポーター、ジョン; Robert Porter John et al. (2021). New TNFα structure for therapeutic use. Patent Number: JP2021109880A.